GNF

GNF is a cutting-edge startup that has been making waves in the healthcare industry since its inception in 1999. A part of the Novartis Institute for Biomedical Research (NIBR), GNF is at the forefront of leveraging state-of-the-art technologies in chemistry, biology, automation, and information sciences. With a workforce of over 560 employees, the company is dedicated to tackling complex biomedical problems across various domains including cancer biology, immunology, neuroscience, and metabolic and infectious diseases.

As a leader in the pharmaceutical industry, GNF's focus on integrated genomics and proteomics tools, medicinal chemistry, and cell-based high throughput screening reinforces its commitment to innovation. Based in the United States, GNF's dedication to advancing medical research is commendable, making it an attractive opportunity for potential investors seeking to support groundbreaking advancements in healthcare.